Defence Therapeutics Inc.: Defence Breakthrough: Successfull

Defence Therapeutics Inc.: Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized

Related Keywords

United Kingdom , Vaccum , Niedersachsen , Germany , Canada , Vancouver , British Columbia , Canadian , British , Sebastien Plouffe , Defence Therapeutics Inc , Precedence Research , British Columbia Newsfile Corp , Defence Therapeutics , Statement Regarding , Defence , Herapeutics , Breakthrough , Uccessfully , Engineered , Rna , Vaccine , Reating , Platform , Ivo , Dancer , Program , Egins ,